Month: May 2022

MARKHAM, Ontario, May 12, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2022. Results are presented in Canadian dollars unless otherwise noted. First Quarter HighlightsHigh community transmission of the Omicron variant resulted in increased outbreaks and high absenteeism across the organization. Consequently, home health care average daily volumes (“ADV”) were 4.8% lower than Q4 2021 and our long-term care (“LTC”) average occupancy dropped by 120 bps. The sale of the Esprit retirement living portfolio is scheduled to close on or about May 16, 2022, for estimated net proceeds of approximately $125.0 million. Process to seek regulatory approvals for Revera and Axium transactions is underway in Manitoba and Ontario. If approved, Extendicare...

CALGARY, Alberta, May 12, 2022 (GLOBE NEWSWIRE) — GINSMS Inc. (TSXV: GOK) (the “Corporation”) has announced its financial results for the first quarter ended March 31, 2022. The complete financial results for GINSMS are available at www.sedar.com. Highlights include:Revenue of $725,536 for the three-month period ended March 31, 2022 as compared of $536,186 for the three-month period ended March 31, 2021. Gross Profit of $270,688 for the three-month period ended March 31, 2022 as compared to gross profit of $215,301 for the three-month period ended March 31, 2021. Operating expenses and finance costs of $195,059 for the three-month period ended March 31, 2022 decreased from $209,618 for the three-month period ended March 31, 2021. Net profit of $75,629 for three-month period ended March 31, 2022 as compared to a net profit of...

CALGARY, Alberta, May 12, 2022 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) announces its operating and record financial results for the first quarter ended March 31, 2022. FINANCIAL AND OPERATING HIGHLIGHTS FROM THE FIRST QUARTER OF 2022First quarter 2022 total production increased 12% over the same period in 2021 with crude oil production increasing by 18%; Adjusted funds flow(1) increased to a record $86.6 million, a 436% increase over the same period in 2021 and a 62% increase over the prior quarter; Adjusted funds flow per share(1) increased by 61% over the prior quarter to $0.58/share and $0.53/diluted share; First quarter 2022 free cash flow(1) increased 46% over the prior quarter to $51.6 million; Net debt(1) decreased $31 million or 17% from the balance at the...

Investigational New Drug (IND)-enabling studies continue to generate promising data that support further development of the company’s lead myotonic dystrophy type 1 (DM1) candidate; new preclinical data to be presented at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting; on track to submit a planned IND application to the U.S. Food and Drug Administration (FDA) in the fourth quarter of calendar year (CY) 2022 On track to nominate a development candidate and initiate scale-up and toxicology activities for a systemically administered, allele-selective candidate for the Huntington’s disease (HD) program in CY2022 Progressed KRAS G12D and G12V oncology programs supported with mechanistic work and in vivo pharmacologyPITTSBURGH and CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc....

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, May 12, 2022 (GLOBE NEWSWIRE) — Northview Fund (“Northview” or the “Fund”) (NHF.UN – TSX), today announced financial results for the three months ended March 31, 2022. All amounts in this news release are in thousands of Canadian dollars unless otherwise indicated. “Occupancy and AMR in the multi-residential portfolio remained stable compared to the fourth quarter of 2021, with occupancy improvements of 110 basis points compared to the first quarter of 2021,” commented Mr. Todd Cook, Chief Executive Officer of Northview. “The current high inflation environment and increasing interest rates continue to put pressure on funds from operations. Northview is focused on managing costs and reducing the amount of floating rate debt...

WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q2 FY 2022”) and six months (“H1 FY 2022”) ended March 31, 2022. Q2 FY 2022 HighlightsRevenue grew 646.3% to $140.3 million, from $18.8 million during the three months ended March 31, 2021 (“Q2 FY 2021”), driven by $30.6 million in accretive sales from internal growth initiatives and $90.9 million from incremental revenue from the acquisitions of HistoTox Labs, Inc. (“HistoTox Labs”), Bolder BioPATH, Inc. (“Bolder BioPATH”), Gateway Pharmacology Laboratories LLC (“Gateway...

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) — The financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by Predictive Oncology Inc. (NASDAQ: POAI) today, disclosing the results for the quarter ended March 31, 2022. The consolidated results of Predictive Oncology’s reportable segments included recognized revenue of $314,568 for the quarter. The artificial intelligence (AI) and data-driven discovery services entity also reported an update on its business operations. Highlights from the quarter included:Discovery 21 and PeDAL® platform validated as Predictive Oncology moves ahead with commercialization. Cash and equivalents were $25 million as of March 31, 2022. The company has not reported any long-term debt obligations in its capital structure. Predictive...

BOCA RATON, Fla., May 12, 2022 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and LTO payment solution provider, today announced its financial results for the quarter ended March 31, 2022. Results for Quarter Ended March 31, 2022 vs. Quarter Ended March 31, 2021:Total fundings increased 1% to $21.2 million from $21.0 million consisting of gross lease originations decreasing 22.0% to $16.3 million from $20.9 million and loan participations up ~5000% from $97 thousand to $4.9 millionTotal net lease revenues and fees decreased 15.2% to $27.8 million from $32.8 millionTotal net loan revenues and fees increased 3,576.4% to $1.2 million from $32 thousandGross profit decreased 8.7% to $9.4 million from $10.3 millionAdjusted EBITDA1 decreased to $(40.3)...

Beat Q1 guidance on both of the non-GAAP metrics we primarily focus on, ex-TAC Gross Profit and Adjusted EBITDA. Revenues of $354.7M grew 17% over Q1 2021. Gross Profit of $112.0M grew 25% and Ex-TAC Gross Profit of $138.2M grew 31% over Q1 2021 and 8.4% pro forma with Connexity**. Generated net income of $3.9M, Non-GAAP Net Income of $21.9M and Adjusted EBITDA of $34.9M. Revising 2022 full year guidance ranges to Ex-Tac Gross Profit of $595M to $615M, and Adjusted EBITDA of $152M to $160M.NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, today announced its results for the quarter ended March 31, 2022. “Q1 was a strong quarter, we beat our ex-TAC Gross Profit and Adjusted EBITDA objectives, growing ex-TAC...

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) — Shawcor Ltd. (“Shawcor” or the “Company”) (TSX: SCL) reported today its operational and financial results for the three months ended March 31, 2022. This press release should be read in conjunction with the Company’s Management Discussion and Analysis (MD&A) and interim consolidated financial statements for the three months ended March 31, 2022, which are available on the Company’s website and at www.sedar.com. Highlights from the first quarter include:The Company exceeded expectations in the first quarter of 2022 with consolidated revenue of $267.8 million, Adjusted EBITDA1 of $20.0 million and operating income of $1.3 million. Shawcor’s businesses serving infrastructure & industrial end markets (formerly described as ‘non-oil & gas’) grew to represent 49% of total revenue...